High-throughput CRISPR technology: a novel horizon for solid organ transplantation

Organ transplantation is the gold standard therapy for end-stage organ failure. However, the shortage of available grafts and long-term graft dysfunction remain the primary barriers to organ transplantation. Exploring approaches to solve these issues is urgent, and CRISPR/Cas9-based transcriptome ed...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xiaohan Li, Zhang Chen, Weicong Ye, Jizhang Yu, Xi Zhang, Yuan Li, Yuqing Niu, Shuan Ran, Song Wang, Zilong Luo, Jiulu Zhao, Yanglin Hao, Junjie Zong, Chengkun Xia, Jiahong Xia, Jie Wu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Immunology
Assuntos:	solid organ transplantation CRISPR/Cas9 transcriptome editing CRISPR screening high-throughput
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1295523/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!